GH Research PLC
- GHRS
- NASDAQ
- Biotechnology
- Psychedelic Therapeutics (5-MeO-DMT)
- Neuro/Psychiatric Drug Development
$18.30
Today +0.80%Quote Oct 19, 2026, 01:54 PM UTC
−36.80%over the last month
Max drawdown −36.8%From 1-month high −36.8%3 months −34.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.13B
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$48.83
+166.9% from here
Floor
$18.20
0.5% below price
Where the price sits
9 analysts
Analyst range, low to high
$39.00$65.00
- Price $18.30
- Resistance $19.65
- Consensus $48.83
The price is just above its floor. Analysts' average target sits about 167% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GHRSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
73
Founded
2018